How is the Verona Pharma Plc - ADR today?

The Verona Pharma Plc - ADR today is trading in the down by -1.89% at 72.69.

How has Verona Pharma Plc - ADR performed historically?

The Verona Pharma Plc - ADR is currently trading down -1.89% on an intraday basis in the past week the index rose 8.11%. The index has been up 6.96% in the past quarter and rose 481.52% in the past year. You can view this in the overview section.

What is Verona Pharma Plc - ADR Annual Net Profit?

Verona Pharma Plc - ADR Annual Net Profit fell 218.96% in the last year to $173.42 M. Its sector's average net profit growth for the last fiscal year was -11.13%.

What is Verona Pharma Plc - ADR Price to Earning Ratio?

Verona Pharma Plc - ADR Price to Earning Ratio is -37.75, which is negative.

What is Verona Pharma Plc - ADR Stock Price?

Verona Pharma Plc - ADR Stock Price rose 481.52% and outperformed its sector by 469.98% in the past year.

What is Verona Pharma Plc - ADR Quarterly Net profit?

Verona Pharma Plc - ADR Quarterly Net profit rose 36.73% YoY to $16.32 M. Its sector's average net profit growth YoY for the quarter was -212.2%.

What is Verona Pharma Plc - ADR Debt to Equity Ratio?

Verona Pharma Plc - ADR Debt to Equity Ratio of 0.6 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Verona Pharma Plc - ADR Return on Equity(ROE)?

Verona Pharma Plc - ADR Return on Equity(ROE) for the last financial year was -76.42%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Verona Pharma Plc - ADR Mutual Fund Holding?

Verona Pharma Plc - ADR Mutual Fund Holding increased by 3.18% in the last quarter to 33.41.

What is Verona Pharma Plc - ADR Interest Coverage Ratio?

Verona Pharma Plc - ADR Interest Coverage Ratio is -5.93, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Verona Pharma Plc - ADR Institutional Holding?

Verona Pharma Plc - ADR Institutional Holding increased by 6.02% in the last quarter to 85.38.

Verona Pharma Plc - ADR XNAS: VRNA

Verona Pharma Plc - ADR Live Share Price Today, Share Analysis and Chart

Name: Verona Pharma Plc - ADR: Is Infosys Ltd. worth buying?
Item: Verona Pharma Plc - ADR
Rating: 1.549472125
Author: Trendlyne DVM scores

Momentum Trap

about

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrin...

72.69 -1.40 (-1.89%)

New 52W High in past week

1.2M XNAS Volume

XNAS 22 May, 2025 5:30 PM (EDT)

Low Financial Strength

22.2 / 100

Expensive Valuation

3.3 / 100

Technically Bullish

76.2 / 100

Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM

1Yr Price target upside is 29%

10 analysts

Verona Pharma Plc - ADR Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Verona Pharma Plc - ADR Live Share Price Today, Share Analysis and Chart

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrin...

New 52W High in past week

SWOT Analysis

Verona Pharma Plc - ADR Live Price Chart

Verona Pharma Plc - ADR FAQ

How is Verona Pharma Plc - ADR today?

Verona Pharma Plc - ADR today is trading in the red, and is down by -1.89% at 72.69.

How has Verona Pharma Plc - ADR performed historically?

Verona Pharma Plc - ADR is currently trading down -1.89% on an intraday basis. In the past week the stock rose 8.11%. stock has been up 6.96% in the past quarter and rose 481.52% in the past year. You can view this in the overview section.